Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 477Neoplasms 292Breast Neoplasms 281Colorectal Neoplasms 223Neoplasm Metastasis 188Prostatic Neoplasms 168Ovarian Neoplasms 166Lung Neoplasms 155Multiple Myeloma 153Recurrence 132Melanoma 116Pancreatic Neoplasms 115Squamous Cell Carcinoma of Head and Neck 105Endometrial Neoplasms 99Stomach Neoplasms 98Leukemia, Myeloid, Acute 97Small Cell Lung Carcinoma 84Leukemia, Lymphocytic, Chronic, B-Cell 83Triple Negative Breast Neoplasms 81Lymphoma, Non-Hodgkin 81Carcinoma, Renal Cell 80Carcinoma, Hepatocellular 77Urinary Bladder Neoplasms 76Lymphoma, Large B-Cell, Diffuse 72Lymphoma, Follicular 64Advanced Solid Tumors 64Lymphoma 60Glioblastoma 57Parkinson Disease 4, Autosomal Dominant Lewy Body 56Head and Neck Neoplasms 54

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Locally Advanced Resectable Rectal Cancer × 90 days × Clear all
NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 2/3 Recruiting
165 enrolled
Gastrointestinal

Locally Advanced Resectable Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡